SCHEMBL11304336

SCHEMBL11304336

O=C(NO)c1ccc(N(c2ccc3ccccc3c2)C2CCNC2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 6/20 0.42
▸ HDAC1 Q13547 9/20 0.41
▸ HDAC8 Q9BY41 6/20 0.41
▸ HDAC3 O15379 4/20 0.41
▸ HDAC7 Q8WUI4 4/20 0.41
▸ HDAC2 Q92769 4/20 0.41
▸ HDAC4 P56524 3/20 0.41
▸ HDAC10 Q969S8 3/20 0.41
▸ HDAC11 Q96DB2 3/20 0.41
▸ HDAC9 Q9UKV0 3/20 0.41
▸ HDAC5 Q9UQL6 3/20 0.41
▸ SLC6A4 P31645 1/20 0.37
▸ GPR6 P46095 1/20 0.36
▸ MMP13 P45452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11296174 0.85 HDAC8 (0.44) HDAC6HDAC1HDAC8HDAC3HDAC7
SCHEMBL11297519 0.84 HDAC6 (0.43) HDAC6HDAC1HDAC8MMP13
SCHEMBL11301404 0.84 HDAC8 (0.47) HDAC6HDAC1HDAC8MMP13
SCHEMBL11302647 0.83 HDAC6 (0.43) HDAC6HDAC1HDAC8HDAC11GPR6
SCHEMBL11298752 0.83 HDAC8 (0.42) HDAC6HDAC1HDAC8
SCHEMBL11296595 0.83 HDAC6 (0.42) HDAC6HDAC1HDAC8HDAC3HDAC7
SCHEMBL11297424 0.83 HDAC1 (0.43) HDAC6HDAC1HDAC8
SCHEMBL11301397 0.83 HDAC1 (0.39) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11296122 0.83 HDAC6 (0.43) HDAC6HDAC1HDAC8HDAC3HDAC7
SCHEMBL11301754 0.82 PSEN1 (0.42) HDAC6HDAC1HDAC8HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
Send feedback